KRASHIA, PARASKEVI
 Distribuzione geografica
Continente #
AS - Asia 1.913
NA - Nord America 243
EU - Europa 174
AF - Africa 4
SA - Sud America 2
OC - Oceania 1
Totale 2.337
Nazione #
SG - Singapore 1.712
US - Stati Uniti d'America 234
CN - Cina 105
HK - Hong Kong 81
IT - Italia 81
GB - Regno Unito 38
DE - Germania 16
NL - Olanda 15
CA - Canada 7
IN - India 7
FI - Finlandia 6
UA - Ucraina 4
ZA - Sudafrica 4
FR - Francia 3
PL - Polonia 3
AT - Austria 2
JP - Giappone 2
MX - Messico 2
PK - Pakistan 2
BR - Brasile 1
CL - Cile 1
GR - Grecia 1
IE - Irlanda 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NR - Nauru 1
SA - Arabia Saudita 1
SE - Svezia 1
TR - Turchia 1
Totale 2.337
Città #
Hong Kong 80
Singapore 58
Hefei 50
Ashburn 40
Rome 37
Boardman 36
London 33
Milan 29
Santa Clara 26
Beijing 20
Shanghai 19
Council Bluffs 18
Los Angeles 12
Buffalo 10
Amsterdam 9
Munich 7
San Francisco 5
Secaucus 5
Turku 5
Brooklyn 4
Pune 4
Cave 3
Charlotte 3
Dallas 3
Johannesburg 3
Roubaix 3
Toronto 3
Warsaw 3
Washington 3
Chennai 2
Hanover 2
Manchester 2
Mexico City 2
Montreal 2
Nanjing 2
New York 2
Redmond 2
Seattle 2
The Dalles 2
Tokyo 2
Xi'an 2
Yangzhou 2
Almere Stad 1
Atlanta 1
Bagheria 1
Bagnaria Arsa 1
Berlin 1
Bradford 1
Cagliari 1
Central 1
Changchun 1
Colombo 1
Denver 1
Dublin 1
Frankfurt am Main 1
Guangzhou 1
Hamburg 1
Helsinki 1
Heraklion 1
Kuala Lumpur 1
Luxembourg 1
Milwaukee 1
Mumbai 1
Nuremberg 1
Phoenix 1
Providence 1
Queens 1
Riga 1
Riyadh 1
St Louis 1
Stockholm 1
São Paulo 1
Vancouver 1
Waldshut-Tiengen 1
Yaren District 1
Totale 590
Nome #
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (Nature Communications, (2019), 10, 1, (3945), 10.1038/s41467-019-11928-w) 194
Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism 193
Incorporation of the β3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors 187
Cisd2: a promising new target in Alzheimer's disease† 182
Hippocampal epileptogenesis in autoimmune encephalitis. 163
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models 155
How dopamine tunes parvalbumin interneurons in the hippocampus: new experimental observations in Alzheimer's disease 125
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease 110
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice 100
Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia. 89
Ambra1 shapes hippocampal inhibition/excitation balance: role in neurodevelopmental disorders 88
Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells 87
Agonist and blocking actions of choline and tetramethylammonium on human muscle acetylcholine receptors 83
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. 83
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease 78
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 69
Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model 67
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease 52
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease 51
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice 38
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases 37
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease 31
Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer’s Disease 29
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease. 25
On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area. 24
The long activations of α2 glycine channels can be described by a mechanism with reaction intermediates ("flip") 23
Totale 2.363
Categoria #
all - tutte 10.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 0 0 0 0 0 1 8 2 0 0 19
2022/202379 0 0 54 3 3 0 0 0 1 0 18 0
2023/202490 4 11 6 12 5 44 0 0 4 2 0 2
2024/20252.017 29 6 45 10 21 42 17 31 55 138 697 926
2025/2026147 108 39 0 0 0 0 0 0 0 0 0 0
Totale 2.363